Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Till Milde

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
Cancer Research|October 13, 2020
Functional Precision Medicine Identifies New Therapeutic Candidates for MedulloblastomaJessica M Rusert, Edwin F Juarez, Sebastian Brabetz, et al.
Acta Neuropathologica|March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusionsHenri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Nature Communications|April 21, 2023
3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymomaKonstantin Okonechnikov, Aylin Camgöz, Owen Chapman, et al.
Cancer Discovery|April 21, 2021
Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial EpendymomasTuyu Zheng, David R Ghasemi, Konstantin Okonechnikov, et al.
European Journal of Cancer (Oxford, England : 1990)|August 2, 2016
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot studyBarbara C Worst, Cornelis M van Tilburg, Gnana Prakash Balasubramanian, et al.
Acta Neuropathologica|February 14, 2023
Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Cancer Cell|March 1, 2016
Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer LandscapesPascal D Johann, Serap Erkek, Marc Zapatka, et al.
Nature Communications|June 5, 2019
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastomaPratiti Bandopadhayay, Federica Piccioni, Ryan O'Rourke, et al.
Acta Neuropathologica|November 27, 2022
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Acta Neuropathologica|August 21, 2021
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrumKaram T Alhalabi, Damian Stichel, Philipp Sievers, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Cancer Research|October 13, 2020
Functional Precision Medicine Identifies New Therapeutic Candidates for MedulloblastomaJessica M Rusert, Edwin F Juarez, Sebastian Brabetz, et al.
Acta Neuropathologica|March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusionsHenri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Nature Communications|April 21, 2023
3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymomaKonstantin Okonechnikov, Aylin Camgöz, Owen Chapman, et al.
Cancer Discovery|April 21, 2021
Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial EpendymomasTuyu Zheng, David R Ghasemi, Konstantin Okonechnikov, et al.
European Journal of Cancer (Oxford, England : 1990)|August 2, 2016
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot studyBarbara C Worst, Cornelis M van Tilburg, Gnana Prakash Balasubramanian, et al.
Acta Neuropathologica|February 14, 2023
Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Cancer Cell|March 1, 2016
Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer LandscapesPascal D Johann, Serap Erkek, Marc Zapatka, et al.
Nature Communications|June 5, 2019
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastomaPratiti Bandopadhayay, Federica Piccioni, Ryan O'Rourke, et al.
Acta Neuropathologica|November 27, 2022
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Acta Neuropathologica|August 21, 2021
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrumKaram T Alhalabi, Damian Stichel, Philipp Sievers, et al.
Pageof 17